Human Papillomavirus in Reproductive Health and Pregnancy: Clinical Implications, Outcomes, and a Comprehensive Review of Vaccination
Current evidence suggests that reproductive risks are more strongly associated with the treatment of HPV-related diseases than with HPV infection itself. Preventive strategies-especially HPV vaccination-remain central to reducing HPV-related disease burden. Although HPV vaccines are not routinely recommended during pregnancy, evidence supports the safety of inadvertent exposure around conception or during gestation, while potential long-term benefits of vaccination regarding reproductive health require further study.
Authors
- Bilal Esat Temiz (ORCID: https://orcid.org/0000-0002-4329-1376)
- Houssein El Hajj (ORCID: https://orcid.org/0000-0001-7613-8354)
- Charlotte S. Goutallier
- Hasan Volkan Ege (ORCID: https://orcid.org/0000-0002-4056-9037)
- Zvi Vaknin (ORCID: https://orcid.org/0000-0003-1086-6644)
- Joanna Kacperczyk‐Bartnik (ORCID: https://orcid.org/0000-0003-2539-3894)
- Gökçen Ege (ORCID: https://orcid.org/0000-0003-2102-3183)
- N Taumberger (ORCID: https://orcid.org/0000-0002-8969-7064)
- Murat Gultekin
- Utku Akgor
- Maria Kyrgiou
- Laura Burney Ellis
- Reda Hemida
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Mansoura University (EG)
- Medical University of Graz (AT)
- Medical University of Warsaw (PL)
- Mercy Hospital for Women (AU)
- Institut Gustave Roussy (FR)
- Graz University Hospital (AT)
- Memorial Ankara Hospital (TR)
- Assaf Harofeh Medical Center (IL)
- National Institute of Oncology (HU)
- Hospital of the Brothers of St. John of God (AT)
- Imperial College London (GB)
- Hacettepe University (TR)
Publication Details
- Journal
- Vaccines
- Published
- 2026-02-14
- DOI
- https://doi.org/10.3390/vaccines14020180
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00